2 thinkers, books, and ideas connected to this field.
Johann Hari's 2024 examination of GLP-1 weight loss drugs (Ozempic, Wegovy) — exploring their effectiveness, side effects, and what their existence reveals about the nature of obesity and appetite.
Danish pharmaceutical company — manufacturer of Ozempic, Wegovy, and Victoza — the company that created the GLP-1 agonist drug class that became the most significant pharmaceutical development of the 2020s.